Feist E, Fatenejad S, Grishin S, Korneva E, et al. Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled Ann Rheum Dis 2022 Sep 15. pii: ard-2022-222630. doi: 10.1136/ard-2022-222630.
PMID: 36109142